Feng Xiao
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
Papers in
-
- Autoimmune and Inflammatory Disorders Research 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Ping Meng (1 shared paper)Xiaoping Pan (1 shared paper)Sumei Li (1 shared paper)Wenbin Qian (7 shared papers)Xianbo Huang (2 shared papers)Renya Zhan (6 shared papers)Hui Liu (2 shared papers)Xiujin Ye (1 shared paper)
- Journals
- Journal of Biomaterials Applications (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Blood (1 paper)Neurological Research (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Feng Xiao
39 papers receiving 630 citations
Peers
Comparison fields: 5 of 69
- Hepatology 61
- Hematology 80
- Cancer Research 79
- Neurology 46
- Oncology 64
Countries citing papers authored by Feng Xiao
This map shows the geographic impact of Feng Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Xiao more than expected).
Fields of papers citing papers by Feng Xiao
This network shows the impact of papers produced by Feng Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Xiao. The network helps show where Feng Xiao may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Xiao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 132 | |
| 2 | 2008 | 69 | |
| 3 | 2016 | 52 | |
| 4 | 2018 | 46 | |
| 5 | 2020 | 40 | |
| 6 | 2012 | 32 | |
| 7 | 2022 | 21 | |
| 8 | 2017 | 20 | |
| 9 | 2018 | 17 | |
| 10 | 2013 | 16 | |
| 11 | 2012 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2015 | 13 | |
| 14 | 2021 | 13 | |
| 15 | 2009 | 11 | |
| 16 | 2022 | 11 | |
| 17 | 2015 | 10 | |
| 18 | 2021 | 10 | |
| 19 | 2021 | 10 | |
| 20 | Overexpression of Sox3 is associated with promoted tumor progression and poor prognosis in hepatocellular carcinoma. | 2017 | 9 |
About Feng Xiao
Feng Xiao is a scholar working on Hematology, Hepatology, Cancer Research, Neurology and Epidemiology, having authored 42 papers that have together received 643 indexed citations. Recurring topics across this work include Nerve Injury and Rehabilitation (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer-related molecular mechanisms research (2 papers), Intracranial Aneurysms: Treatment and Complications (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Meningioma and schwannoma management (2 papers), MicroRNA in disease regulation (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). The work is most often cited by research in Hepatology (61 citations), Hematology (80 citations), Cancer Research (79 citations), Neurology (46 citations) and Oncology (64 citations). Feng Xiao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ping Meng, Xiaoping Pan, Sumei Li, Wenbin Qian, Xianbo Huang, Renya Zhan, Hui Liu, Xiujin Ye, Yanling Ren and Yuan Li. Their work appears in journals such as Journal of Biomaterials Applications, Journal of Experimental & Clinical Cancer Research, Blood, Neurological Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.